Vice President of Corporate Development

About Prenosis

Prenosis Inc. is an artificial intelligence company pioneering precision medicine in acute care. Our Immunix™ precision medicine platform drives the development of precision products and enables real-time delivery of optimal therapy. We've created and validated the first FDA-authorized AI biomarker for sepsis, the Sepsis ImmunoScore®.

At Prenosis, we:

• Put patients first

• Disrupt with evidence

• Excel with integrity

• Go far together

Our staff collectively defined these corporate values to demonstrate how our teams contribute to meaningful and authentic change in U.S. healthcare. We value our diverse talent, strive to foster a culture of continuous learning, and aim to maintain a feeling of belonging and shared sense of purpose.

Prenosis is headquartered in Chicago Illinois and generally operates on Central Time Zone.

Position Summary

We are seeking an ambitious, deal-oriented Vice President of Corporate Development to lead our global strategic partnership initiatives, commercial expansion, and capital development strategies. Reporting directly to Executive Leadership, you will serve as the primary architect and negotiator of transformational alliances across biopharma, Contract Research Organizations (CROs), healthcare systems, and top-tier artificial intelligence companies.

In this role, you will scale commercial adoption of the Sepsis ImmunoScore®, expand the clinical footprint of the Immunix® platform, pioneer novel AI Companion Diagnostic (AI CDx) deal models, and support investor fundraising activities.

Responsibilities

1. Biotech & Big Pharma AI CDx Partnerships

• Structure, negotiate, and execute strategic companion diagnostic (AI CDx) partnerships pairing Prenosis’ proprietary AI algorithms with biotech and pharmaceutical drug candidates.

• Design innovative commercial frameworks, including revenue-sharing models on drug sales where Prenosis' AI CDx platform enables clinical trial success or targeted therapy delivery.

2. Strategy Definition & Product Roadmap Alignment

• Define the overarching corporate strategy for biopharma and commercial engagement.

• Partner with internal R&D, product, and regulatory teams to align product roadmaps with high-value market opportunities and commercial success criteria.

3. Commercial Adoption at Non-Research Clinical Sites

• Spearhead commercial partnership negotiations for Sepsis ImmunoScore® and pipeline diagnostic products, driving adoption across non-research, community, and regional health systems.

• Expand enterprise utilization of the Immunix® platform to establish Prenosis as the standard of care for acute risk prediction.

4. Contract Research Organization (CRO) Alliances

• Negotiate and sign strategic agreements with leading CROs to integrate the Immunix® platform into clinical trials for their biotech/pharma sponsors.

• Establish monetization frameworks that yield recurring fee-for-service, platform access, or milestone payments to Prenosis from CROs and/or biopharma clients.

5. Next-Gen AI & Tech Collaborations (LLM Integration)

• Identify, negotiate, and establish strategic alliances with prominent AI technology companies to co-develop Large Language Model (LLM) interfaces for Prenosis AI Dx and AI CDx products.

• Evaluate and negotiate potential strategic corporate investments, equity participation, or joint ventures connected to these high-tech collaborations.

6. Investor Relations & Capital Fundraising

• Support executive leadership and the Board of Directors in capital-raising initiatives.

• Engage with venture capital, growth equity, and strategic investors, assisting with deal structuring, financial modeling, and pitch presentations to fund company expansion.

Qualifications and Experience

Required:

• Experience: Minimum of 10 years of progressive experience in Business Development (BD) or Corporate Development roles within biotech companies, CROs, or big pharma.

• Proven Track Record: Demonstrated success in structuring, negotiating, and closing complex biopharma licensing, CDx, co-development, or strategic partnership agreements.

• CDx & Digital Health Acumen: Deep understanding of companion diagnostics (CDx), biomarker strategy, digital health/SaMD commercialization, and biopharma drug development pipelines.

• Deal Structuring & Financial Acumen: Advanced capability to build financial models, structure milestone/royalty frameworks, and execute high-value revenue-sharing agreements.

• AI & Tech Literacy: Strong working knowledge of emerging AI paradigms (including LLMs) and their practical integration into clinical workflows and enterprise healthcare systems.

• Fundraising Familiarity: Experience working with institutional investors, supporting Series/Growth raises, or managing strategic corporate investor relations.

• Communication & Leadership: Superior negotiation, presentation, and relationship-building skills with the ability to influence C-suite executives, biopharma leadership, and clinical stakeholders.

• Strategic Dealmaking: Ability to take deals from origination through term sheet and definitive agreement execution.

• Biopharma Partnership Architecture: Expertise in aligning diagnostic platforms with therapeutic pipeline strategies.

• Cross-Functional R&D & Product Alignment: Translating market needs into concrete technical product roadmaps.

• Commercial Drive: Relentless focus on top-line revenue generation and clinical market penetration.

What We Offer

• Comprehensive Medical, dental, and vision coverage

• 401(k) with company match

• Unlimited time off

• Major opportunity for career development to make significant impact at an exciting growth-stage company

• Collaborative and innovative work environment

• Chance to make a real impact on patient care

• Opportunity to work on cutting-edge AI technology in healthcare

Prenosis is an Equal Opportunity Employer

Must be eligible to work in the US without sponsorship